Cancer Meeting Focuses on Existing Drugs

Many of the studies presented at this year's ASCO conference centered on finding better ways to use current cancer treatments

One of the biggest challenges in modern-day cancer treatment is properly matching one or more of the many new cancer drugs to the patients most likely to respond. Consequently, much of the news coming out of the massive American Society of Clinical Oncology (ASCO) meeting focused on better ways to use existing treatments. More than 30,000 oncologists, scientists, and investors who attended the conference in Chicago May 30-June 3 came to learn.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.